MRVI FY 2019 Earnings — Maravai LifeSciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

MRVIMaravai LifeSciences Holdings, Inc.

$970M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$143M+15.6% YoY

Gross Profit

$76M53.3% margin

Operating Income

$24M16.8% margin

Net Income

-$8M-5.9% margin

EPS (Diluted)

$-0.05

Cash Flow

Operating Cash Flow

$24M

Free Cash Flow

$7M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$578M

Total Liabilities

$433M

Stockholders' Equity

$141M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$143M	$124M	+15.6%
Gross Profit	$76M	$63M	+21.0%
Operating Income	$24M	$16M	+45.9%
Net Income	-$8M	-$18M	+52.1%